Management of Upper Respiratory Infections

Initial Assessment and Diagnostic Approach

The initial approach to managing an upper respiratory infection (URI) in an office setting should focus on determining severity, identifying potential bacterial infection, and providing appropriate supportive care while avoiding unnecessary antibiotic use, as recommended by the American Academy of Family Physicians 1
Begin with a detailed history and clinical examination to determine whether the patient can be managed at home or requires hospital referral due to signs of severity, with a strength of evidence rated as high by the British Medical Journal 2, 3
Most URIs are viral in nature, with fewer than 2% complicated by bacterial infection, according to the Centers for Disease Control and Prevention 4
Assess for red flags indicating sepsis or other serious illness that would require immediate intervention, with a high level of evidence supporting this approach from the British Medical Journal 5
Discolored nasal discharge alone does not indicate bacterial infection; it is a sign of inflammation rather than bacterial infection, as stated by the American Academy of Pediatrics 1, 4

Provide symptomatic treatment with analgesics/antipyretics such as acetaminophen or ibuprofen for pain, fever, and inflammation, as recommended by the American College of Physicians 1
Recommend adequate hydration and rest as supportive measures, with a moderate level of evidence supporting this approach from the American Academy of Family Physicians 1
Consider saline nasal irrigation for minor improvement in nasal symptoms, with a low level of evidence supporting this approach from the American College of Physicians 1
Oral decongestants may provide symptomatic relief if no contraindications exist, with a moderate level of evidence supporting this approach from the American Academy of Family Physicians 1
Antibiotics should NOT be prescribed for viral URIs as they are ineffective and contribute to antibiotic resistance, as stated by the Centers for Disease Control and Prevention 1

Assess for risk factors that may complicate the course of infection, including age >65 years, comorbidities (COPD, cardiovascular disease, diabetes), and recent antibiotic use, with a high level of evidence supporting this approach from the European Respiratory Journal 7, 3
For patients with pneumonia, use CRB65 score to inform decisions about the appropriate care pathway, with a moderate level of evidence supporting this approach from the British Medical Journal 5
Consider home management impossible in cases of vomiting, social exclusion, extreme poverty, dependency, poor likelihood of compliance, or altered mental status, with a low level of evidence supporting this approach from the European Respiratory Journal 8

Provide clear safety netting advice to patients who are self-managing, with a moderate level of evidence supporting this approach from the British Medical Journal 5
Advise patients to return if symptoms persist beyond 3 weeks, fever exceeds 4 days, dyspnea worsens, or if the patient stops drinking or consciousness decreases, with a high level of evidence supporting this approach from the American Academy of Family Physicians 1
If a patient with suspected bacterial infection fails to respond to initial treatment within 48-72 hours, they should be reassessed, with a moderate level of evidence supporting this approach from the American College of Physicians 1

Prescribing antibiotics for viral URIs (ineffective and contributes to resistance), as stated by the Centers for Disease Control and Prevention 1
Relying on imaging studies to diagnose acute bacterial sinusitis, with a high level of evidence supporting this approach from the American College of Physicians 1, 4
Assuming purulent nasal discharge indicates bacterial infection, with a moderate level of evidence supporting this approach from the American Academy of Pediatrics 1, 4
Delaying antibiotic therapy when truly indicated for bacterial infections, with a high level of evidence supporting this approach from the European Respiratory Journal 6